Symbia Intevo

See the Difference with xSPECT—Total Integration of SPECT and CT

Symbia Intevo
 
Contact Us

See the Unseen

Make confident decisions

Symbia Intevo™1 redefines SPECT/CT with ultra-high imaging and for the first time, quantification of SPECT. Physicians now have access to more diagnostic information to aid them in differentiating cancer from other forms of disease for bone imaging. Now more than ever before, physicians are able to see the unseen. The precise alignment of SPECT and CT provided by xSPECT improves image contrast and small volume accuracy to further assist physicians with confident decision making. This increases reading confidence and the ability to monitor and adjust treatments earlier.

 

Your Return on Innovation


Easier Decision Making

With high image contrast and precise lesion characterization xSPECT is designed to help reduce the need for additional costly follow-up procedures. Overall it facilitates easier physician decision making and as an example supports physicians in distinguishing degenerative disease from cancer.


Increase Reading Confidence
Symbia Intevo has the ability to increase physician’s reading confidence by offering better visual localization of lesions compared to conventional SPECT/CT technology.


Reduce Interpretation Time
Single-step reading with integrated xSPECT Bone images may reduce time to read and report.


Early Treatment Decisions
Finest image detail can potentially help initiate earlier treatment decisions and reduce length of stay.
 

Expand Referral Base
Higher diagnostic image quality may improve referring physician acceptance and increase patient volume.


Reduce Costly Follow-Ups
Clearer images potentially reduce the need for costly CT, MR or biopsy follow-ups.


Access to Research Grants
The enhanced clinical opportunities provided by xSPECT may unlock new medical applications and advance future areas of research.

 

1Symbia Intevo and xSPECT are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.



Quantify the Difference

Monitor and adjust patient treatment earlier

Symbia Intevo™1 is the first SPECT/CT system with one of a kind xSPECT technology to allow easy, accurate and reproducible quantification, making treatment follow-up possible. Symbia Intevo, with xSPECT Quant, integrates SPECT count rate for 99mTc studies with CT volume and tissue density information to create a quantitative xSPECT image.

Your Return on Innovation


Early Treatment Modification
Quantitative accuracy may enable early modification of patient treatment to reduce side effects from ineffective therapies.


More Confident Interpretation

Quantification may support physicians with more confident clinical interpretation (e.g., liver imaging).


Automated Quantification
Fully automated quantitative reconstruction saves time compared to inefficient manual processes.


One-Click Analysis
One-click quantitative analysis software eliminates up to 22 time consuming steps2 typically performed for conventional SPECT.


Expand Clinical Applications

With xSPECT Quant institutions can potentially expand applications, improve referring physician satisfaction and increase reimbursement.


Reduce Ineffective Treatment Costs
By quantifying small differences, Symbia Intevo may enable early treatment change and may save costs with ineffective cancer drugs affecting up to 75% of patients.3


1Symbia Intevo and xSPECT are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
2As compared to Mediso Post-Processing quantification steps.
3Brian B. Spear, Margo Heath-Chiozzi, Jeffrey Huff, “Clinical Trends in Molecular Medicine, Volume 7, Issue 5, 1 May 2001, Pages 201-204.



Adapt the Lowest Dose

Support diagnosis and treatment of challenging diseases

With half the dose and double the speed, healthcare providers can potentially improve patient well-being, reduce costs and increase productivity. Symbia Intevo paves the way for extraordinary progress in diagnosing and treating the most challenging diseases.
 

Principles such as As Low as Reasonably Achievable (ALARA) guide the reduction of all radiation exposure to the lowest possible level. With CARE (Combined Applications to Reduce Exposure), Siemens has been highly successful integrating many innovations into its systems that significantly reduce radiation dose compared to conventional SPECT/CT systems.

Your Return on Innovation


Reduce Radiation Risk

By offering automated dose modulation, flexible CT protocols and unique collimator design, Symbia Intevo1 enables up to 74%2 lower CT radiation and up to 26%2 reduction in injected dose to reduce long-term patient radiation risk.


Reduced Setup Time
CARE Dose4D™ automatically modulates dose on-the-fly, eliminating the need for manual dose adjustments.


Readily Available Dose Documentation
Integrated dose reports and dose alerts enable easier and more efficient documentation of patient radiation exposure.


Increase Referral Base
By offering the lowest2 patient radiation exposure, institutions may attract more patients and expand their referral base.


Up to 26% Reduction in Radioisotope Cost

With unique AUTOFORM collimator technology, Symbia Intevo allows for up to 26% lower dose2, saving radioisotope costs.


Lower Lifecycle Cost
By adapting the lowest dose, Symbia Intevo uses less CT tube voltage and current, potentially extending tube life.

 

1Symbia Intevo and xSPECT are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
2Based on competitive literature available at time of publication. Data on file.



Double the Troughput

Increase efficiency and utilization

Time affects all aspects of daily imaging from patient comfort to staff productivity.
With increasing patient demand and decreasing reimbursement levels, efficiency and productivity are essential. Routine manual tasks take away time and resources that could be better used in patient preparation, scanning and processing.


Understanding the need for higher workflow efficiency, Siemens has introduced several unique and proprietary solutions that optimize operational efficiency, increase utilization and enable the potential to double patient throughput.


Your Return on Innovation


Reduced Motion Artifacts
Symbia Intevo’s1unique cardiac imaging solution, IQ•SPECT improves acquisition time by up to 75% for enhanced patient comfort and fewer motion artifacts.


Improve Diagnostic Confidence

The unique Automated Quality Control feature provides consistent image quality, supporting higher diagnostic confidence.


Save One Hour Daily
Symbia Intevo offers a series of automation features, such as Automated Quality Control and Automated Collimator Changer, which can save, on average, one hour of staff time each day.


Reduce Patient Waiting List
With unique collimator designs, institutions have now the potential to reduce patient waiting list with up to 75% more cardiac counts and 26%2 more bone counts.


Expand Referral Base
Symbia Intevo’s faster imaging solutions improve patient comfort and satisfaction, potentially expanding the institution’s referral base.


Double the Throughput

By combining all of Symbia Intevo’s unique productivity features, institutions can have up to 50% time savings and, as a result, the potential to double patient throughput. 
 

1Symbia Intevo and xSPECT are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
2Based on competitive literature available at time of publication. Data on file
.


Related Products, Services & Resources